Skip to main content
. 2016 Nov 7;6:36037. doi: 10.1038/srep36037

Figure 5. Increased myofibroblasts in TSC1 CKO Mice.

Figure 5

(A) Liver tissue samples from oil- or CCl4− treated mice were analyzed for PARP, cleaved caspase-3, p-S6, and S6 protein by western blot analysis. Immunofluorescence (IF) staining were performed to evaluate the impact of TSC1 deletion on myofibroblasts proliferation and apoptosis. (B) Sections were stained with α-SMA (green) and p-S6 (red) antibodies. There were increased both α-SMA and pS6 positive cells in TSC1 CKO mice administered CCl4. (C) Sections were stained with α-SMA (red) and ki67 (green) antibodies. Both α-SMA- and ki67-positive cells were increased in TSC1 CKO mice following CCl4 treatment. (D) Sections were stained with α-SMA (green) and cleaved caspase-3 (red) antibodies. Both α-SMA- and cleaved caspase-3-positive cells decreased in the CCl4− treated TSC1 CKO mice. Tissues were counterstained with DAPI (blue) to detect nuclei and imaged at 400x magnification.